Clinical Implications of Low Absolute Blood Eosinophil Count in the SPIROMICS COPD Cohort

LeMaster, W. B., Quibrera, P. M., Couper, D., Tashkin, D. P., Bleecker, E. R., Doerschuk, C. M., Ortega, V. E., Cooper, C., Han, M. K., Woodruff, P. G., O’Neal, W. K., Anderson, W. H., Alexis, N. E., Bowler, R. P., Barr, R. G., Kaner, R. J., Dransfield, M. T., Paine, R., Kim, V., … Barjaktarevic, I. (2023). Clinical Implications of Low Absolute Blood Eosinophil Count in the SPIROMICS COPD Cohort. Chest, 163(3), 515–528. https://doi.org/10.1016/j.chest.2022.10.029
Authors:
W Blake LeMaster
P Miguel Quibrera
David Couper
Donald P Tashkin
Eugene R Bleecker
Claire M Doerschuk
Victor E Ortega
Christopher Cooper
MeiLan K Han
Prescott G Woodruff
Wanda K O'Neal
Wayne H Anderson
Neil E Alexis
Russell P Bowler
R Graham Barr
Robert J Kaner
Mark T Dransfield
Robert Paine
Victor Kim
Jeffrey L Curtis
Fernando J Martinez
Annette T Hastie
Igor Barjaktarevic
Affiliated Authors:
R Graham Barr
Author Keywords:
copd
eosinophil
gold group d
inhaled corticosteroid
Publication Type:
Article
Unique ID:
10.1016/j.chest.2022.10.029
PMID:
Journal:
Publication Date:
Data Source:
PubMed

Record Created: